Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Virginia Mason Multiple Sclerosis Center is a specialized clinical and research facility based in Seattle, Washington, focused on providing comprehensive care for patients with multiple sclerosis and related neuroimmunological conditions. As a designated Center for Comprehensive MS Care by the National Multiple Sclerosis Society, it employs a multidisciplinary team including neurologists, specialized nurses, and rehabilitation therapists. The center is a key site for clinical research, frequently partnering with the Benaroya Research Institute to conduct Phase 1 through Phase 3 clinical trials for novel disease-modifying therapies. Their services encompass advanced diagnostics, infusion therapy, and long-term disease management. Now part of the Virginia Mason Franciscan Health system, the center remains a regional leader in neurological care and autoimmune research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virginia Mason Multiple Sclerosis Center.